ADMA Biologics Inc (ADMA) financials · P/E 22, rev $238.9M
ADMA Biologics Inc (ADMA) P/E 22, rev $238.9M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $510.2M | $426.5M |
| Cost of Revenue | $217.4M | $206.9M |
| Gross Profit | $292.8M | $219.6M |
| Operating Income | $191.4M | $139.0M |
| Net Income | $146.9M | $197.7M |
| EPS (Diluted) | $0.60 | $0.81 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $624.2M | $488.7M |
| Current Assets | $466.5M | $331.4M |
| Cash & Equivalents | $87.6M | $103.1M |
| Inventory | $206.5M | $170.2M |
| PP&E | $65.1M | $54.7M |
| Total Liabilities | $146.9M | $139.7M |
| Current Liabilities | $69.5M | $55.5M |
| Short-term Debt | $2.8M | $0 |
| Long-term Debt | $69.3M | $72.3M |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $477.3M | $349.0M |
| Retained Earnings | -$161.7M | -$308.6M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $50.4M | $118.7M |
| CapEx | $22.6M | $8.2M |
| Investing Cash Flow | -$21.9M | -$8.6M |
| Financing Cash Flow | -$44.0M | -$58.3M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | -$15.5M | $51.8M |
| Free Cash Flow | $27.8M | $110.4M |
FAQ
What is ADMA P/E and revenue?
ADMA Biologics Inc (ADMA) P/E 22, rev $238.9M.
What is ADMA revenue?
ADMA Biologics Inc last cached revenue is $510.2M (FY2025).
Is ADMA profitable?
ADMA Biologics Inc last cached net income is $146.9M.
What are ADMA total assets?
ADMA Biologics Inc last cached total assets are $624.2M.
What is ADMA free cash flow?
ADMA Biologics Inc last cached free cash flow is $27.8M.
Not investment advice. Cached statements, not a live tape.